Cigna paying members to use biosimilars draws providers ire
Cigna pays members to switch to biological drugs that it says are clinically equivalent and cheaper—a new policy provoking objections [...]
2021 Thematic Research Report on Patient Access to Healthcare – Featuring Medtronic, Dexcom and Cigna Among Others – ResearchAndMarkets.com
DUBLIN, July 19, 2021 --( BUSINESS WIRE )--The "Patient Access to Healthcare - Thematic Research" report has been added to [...]
Policy, Progress, Pace: Is the NHS finally able to move past siloed technology?
With NHSX driving a new data strategy alongside an evolution in electronic patient records, the health service is primed to [...]
Expanding the public and patient role in medical regulation
A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public [...]
Minimizing Luck In Study Feasibility
Clinical trial failure is both inevitable and multi-factorial. Translational research often reaches dead ends as the complexity of human biology [...]
Amazon Launches AWS for Health and Amazon HealthLake Data Analysis Tool
Amazon has announced the launch of AWS for Health, which will partner with pharma and healthcare organizations and offer a [...]
Report Highlights the Impact of the COVID-19 Pandemic on Healthcare Preferences
A new report features insight from a survey of 1,000 participants. Key trends include a shift to virtual care, online [...]
Whitepaper Details Using Social Media as a Source of RWD
A new whitepaper published in The Evidence Forum highlights a typically overlooked source of real world data (RWD)—social media. Posts [...]
Understanding Japan’s 22 Robust RWD Databases
Japan boasts 22 databases that include patient data. Gaining access to the real world data (RWD) can be tricky and [...]
RWE Whitepaper Discusses Using EMRs and HIE Technology to Gain Insight Into Patient Outcomes
A whitepaper published in Evidera’s The Evidence Forum discusses real world evidence (RWE) applications in determining patient outcomes. The article [...]
Why NLP Is the Key to Interpreting Unstructured Data in Pharma Drug Discovery
Natural Language Processing is a field of AI, which draws disciplines from computational linguistics and computer science to help machines [...]
New Roadmap for High-Quality Cancer Care Delivery
The newly issued comprehensive ‘Oncology Medical Home’ standards can act as a roadmap for how practices can deliver high-quality cancer [...]
ICH Will Develop RWE Guidelines To Assess Drug Safety
The International Council for Harmonisation (ICH) recently held a virtual meeting. It announced the development of guidelines that will be [...]
Specialty Pharmacy Needs Greater Transparency and Equity to Avoid Federal Surveillance
According to Informa Connect’s recent meeting on specialty pharma, increased transparency is needed to avoid headaches stemming from federal surveillance [...]
ISPOR Holds Short Course on HEOR Advanced Decision Modeling
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will hold a virtual short course on July 27th and 28th at 9:00 AM [...]
Aetion eBook Notes Half of 2019 Submissions to FDA Included RWE
Aetion has released an eBook detailing trends in regulatory submissions that include real world evidence (RWE). Aetion notes that approximately [...]
Aetion Discusses RWE in FDA’s Review of Multiple Myeloma Drug
The Food and Drug Administration (FDA) approved ABECMA for use in patients with relapsed or refractory multiple myeloma. The FDA [...]
HealthVerity Discusses COVID-19, Booster Vaccines, and RWD
As variants of the COVID-19 virus emerge, included the concerning delta variant, pharmaceutical companies are suggesting that a booster shot [...]
Biogen Unsuccessful in ICER Attack as Aduhelm Controversy Continues
Biogen has attempted to shield itself from the Institute for Clinical and Economic Review (ICER)’s objections to its Alzheimer’s drug, [...]
Voters Seek to Maintain Access to Medication Through Medicare
A recent poll showed that voters strongly support access to prescription drugs through Medicare Part D. In addition, voters are [...]
A Brief History of Pharmacy Benefit Managers (How They Became the “Shady Middle Men” in the Drug Market)
This is a guest post by Taylor J. Christensen, M.D. (@taylorjayc). Dr. Christensen is an internal medicine physician and health [...]
CrossBridge Health Acquires Geisinger-developed PACER Software
Geisinger’s Patient Centric Electronic Redesign (PACER) patient monitoring and clinical workflow software has been acquired by CrossBridge Health , a [...]
Reducing Administrative Costs in US Health Care: Assessing Single Payer and Its Alternatives
The following guest post is by David Scheinker, Barak Richman, Arnold Milstein, and Kevin Schulman. Administrative costs in the US [...]
Model Estimates Little Impact on US Payer Budgets by the Use of Selinexor, Bortezomib, Dexamethasone in Previously-Treated Multiple Myeloma
According to the results of a study published in ClinicoEconomics and Outcomes Research, the introduction of selinexor, bortezomib, and dexamethasone [...]
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients Seite 1
OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans ROCHESTER, Mich., [...]